MediaPharma
MediaPharma is an Italian drug discovery Biotech company active in oncology and focused on human antibodies and ADCs.
Industries
Nr. of Employees
small (1-50)
Products
MP-1959-ADC
A humanized antibody-drug conjugate targeting Galectin-3 Binding Protein (Gal-3 BP) for cancer treatment, designed to induce tumor shrinkage in various cancers overexpressing Gal-3 BP.
Monoclonal Antibodies
Monoclonal antibodies developed for research and therapeutic use in oncology and other severe diseases.
Antibody-Drug Conjugates (ADCs)
Therapeutic agents combining monoclonal antibodies with cytotoxic drugs to target and kill cancer cells.
Personalized Medicine and Companion Diagnostics
Development of assays and biomarkers to identify patients likely to respond to specific anticancer therapies for tailored treatment.
Research Products Catalogue (Monoclonal Antibodies for Research)
A catalogue of monoclonal antibodies available for laboratory research use targeting various human proteins.
Human IFN-a1 Antibody
A mouse monoclonal antibody specific for human interferon alpha 1, intended for laboratory research use.
MP-1959-ADC
A humanized antibody-drug conjugate targeting Galectin-3 Binding Protein (Gal-3 BP) for cancer treatment, designed to induce tumor shrinkage in various cancers overexpressing Gal-3 BP.
Monoclonal Antibodies
Monoclonal antibodies developed for research and therapeutic use in oncology and other severe diseases.
Antibody-Drug Conjugates (ADCs)
Therapeutic agents combining monoclonal antibodies with cytotoxic drugs to target and kill cancer cells.
Personalized Medicine and Companion Diagnostics
Development of assays and biomarkers to identify patients likely to respond to specific anticancer therapies for tailored treatment.
Research Products Catalogue (Monoclonal Antibodies for Research)
A catalogue of monoclonal antibodies available for laboratory research use targeting various human proteins.
Human IFN-a1 Antibody
A mouse monoclonal antibody specific for human interferon alpha 1, intended for laboratory research use.